- Home
- IMNM vs GDEN Comparison
IMNM vs GDEN Comparison
Compare IMNM & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- GDEN
- Stock Information
- Founded
- IMNM 2006
- GDEN 1998
- Country
- IMNM United States
- GDEN United States
- Employees
- IMNM N/A
- GDEN N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- GDEN Services-Misc. Amusement & Recreation
- Sector
- IMNM Health Care
- GDEN Consumer Discretionary
- Exchange
- IMNM Nasdaq
- GDEN Nasdaq
- Market Cap
- IMNM 770.1M
- GDEN 705.7M
- IPO Year
- IMNM 2020
- GDEN 1999
- Fundamental
- Price
- IMNM $7.46
- GDEN $27.32
- Analyst Decision
- IMNM Strong Buy
- GDEN Strong Buy
- Analyst Count
- IMNM 5
- GDEN 7
- Target Price
- IMNM $26.40
- GDEN $36.86
- AVG Volume (30 Days)
- IMNM 1.1M
- GDEN 159.0K
- Earning Date
- IMNM 05-16-2025
- GDEN 05-08-2025
- Dividend Yield
- IMNM N/A
- GDEN 3.66%
- EPS Growth
- IMNM N/A
- GDEN N/A
- EPS
- IMNM N/A
- GDEN 0.39
- Revenue
- IMNM $9,041,000.00
- GDEN $653,614,000.00
- Revenue This Year
- IMNM N/A
- GDEN $2.32
- Revenue Next Year
- IMNM $1,259.12
- GDEN $2.80
- P/E Ratio
- IMNM N/A
- GDEN $70.33
- Revenue Growth
- IMNM N/A
- GDEN N/A
- 52 Week Low
- IMNM $5.15
- GDEN $22.66
- 52 Week High
- IMNM $19.07
- GDEN $35.49
- Technical
- Relative Strength Index (RSI)
- IMNM 43.56
- GDEN 58.80
- Support Level
- IMNM $7.15
- GDEN $25.28
- Resistance Level
- IMNM $9.16
- GDEN $26.67
- Average True Range (ATR)
- IMNM 0.51
- GDEN 0.85
- MACD
- IMNM -0.08
- GDEN 0.20
- Stochastic Oscillator
- IMNM 15.42
- GDEN 83.40
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.